{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T09:27:28Z","timestamp":1784280448419,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.canep.2023.102515","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T04:51:44Z","timestamp":1704343904000},"page":"102515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The reduced mortality of malignant melanoma at the population level is mainly attributable to treatment advances for the past decade"],"prefix":"10.1016","volume":"88","author":[{"given":"Si","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4281-5254","authenticated-orcid":false,"given":"Jianglong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenmin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2743-9529","authenticated-orcid":false,"given":"Zhenming","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.canep.2023.102515_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canep.2023.102515_bib2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejca.2015.09.013","article-title":"Survival of patients with advanced metastatic melanoma: the impact of novel therapies","volume":"53","author":"Ugurel","year":"2016","journal-title":"Eur. J. Cancer"},{"issue":"8","key":"10.1016\/j.canep.2023.102515_bib3","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med"},{"issue":"26","key":"10.1016\/j.canep.2023.102515_bib4","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.canep.2023.102515_bib5","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s40265-013-0095-2","article-title":"Dabrafenib: first global approval","volume":"73","author":"Ballantyne","year":"2013","journal-title":"Drugs"},{"issue":"11","key":"10.1016\/j.canep.2023.102515_bib6","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s40265-013-0096-1","article-title":"Trametinib: first global approval","volume":"73","author":"Wright","year":"2013","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.canep.2023.102515_bib7","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1158\/2159-8290.CD-NB2015-055","article-title":"Pembrolizumab superior to ipilimumab in melanoma","volume":"5","year":"2015","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.canep.2023.102515_bib8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa1302369","article-title":"Nivolumab plus ipilimumab in advanced melanoma","volume":"369","author":"Wolchok","year":"2013","journal-title":"N. Engl. J. Med"},{"issue":"12","key":"10.1016\/j.canep.2023.102515_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.45269","article-title":"Melanoma treatments and mortality rate trends in the US, 1975 to 2019","volume":"5","author":"Kahlon","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.canep.2023.102515_bib10","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence -SEER 12 Regs: National Cancer Institute; 2022 [Available from: https:\/\/seer.cancer.gov\/data\/]. (Accessed: 30 July 2023\uff09."},{"issue":"12","key":"10.1016\/j.canep.2023.102515_bib11","first-page":"1117","article-title":"The surveillance, epidemiology, and end results program: a national resource","volume":"8","author":"Hankey","year":"1999","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"9","key":"10.1016\/j.canep.2023.102515_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx030","article-title":"Annual report to the Nation on the Status of Cancer, 1975-2014, featuring survival","volume":"109","author":"Jemal","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"issue":"12","key":"10.1016\/j.canep.2023.102515_bib13","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/0895-4356(94)90089-2","article-title":"A method for partitioning cancer mortality trends by factors associated with diagnosis: an application to female breat cancer","volume":"47","author":"Chu","year":"1994","journal-title":"J. Clin. Epidemiol."},{"issue":"6","key":"10.1016\/j.canep.2023.102515_bib14","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1634\/theoncologist.8-6-541","article-title":"Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) Program","volume":"8","author":"Gloeckler Ries","year":"2003","journal-title":"Oncologist"},{"issue":"7","key":"10.1016\/j.canep.2023.102515_bib15","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1916623","article-title":"The effect of advances in lung-cancer treatment on population mortality","volume":"383","author":"Howlader","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canep.2023.102515_bib16","unstructured":"Joinpoint trend analysis software: National Cancer Institute; 2022 [Available from: https:\/\/surveillance.cancer.gov\/joinpoint\/]. (Accessed: 7 July 2023\uff09."},{"issue":"11","key":"10.1016\/j.canep.2023.102515_bib17","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1158\/1055-9965.EPI-14-0300","article-title":"A web tool for age-period-cohort analysis of cancer incidence and mortality rates","volume":"23","author":"Rosenberg","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.canep.2023.102515_bib18","unstructured":"Age-Period-Cohort analysis tool: National Cancer Institute; 2014 [Available from: https:\/\/analysistools.cancer.gov\/apc\/]. (Accessed: 30 July 2023\uff09."},{"issue":"5","key":"10.1016\/j.canep.2023.102515_bib19","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2105\/AJPH.2020.305567","article-title":"New Systematic Therapies and Trends in Cutaneous Melanoma Deaths Among US Whites, 1986-2016","volume":"110","author":"Berk-Krauss","year":"2020","journal-title":"Am. J. Public Health"},{"issue":"5","key":"10.1016\/j.canep.2023.102515_bib20","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/jamaoncol.2022.0134","article-title":"Differences in thickness-specific incidence and factors associated with cutaneous melanoma in the US From 2010 to 2018","volume":"8","author":"Chen","year":"2022","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.canep.2023.102515_bib21","unstructured":"Drugs approved for melanoma: National Cancer Institute.; 2022 [Available from: https:\/\/www.cancer.gov\/about-cancer\/treatment\/drugs\/melanoma]. (Accessed: 15 July 2023\uff09."},{"issue":"4","key":"10.1016\/j.canep.2023.102515_bib22","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1007\/s12032-010-9606-0","article-title":"Continuous systemic corticosteroids do not affect the ongoing regression of metastatic melanoma for more than two years following ipilimumab therapy","volume":"28","author":"Harmankaya","year":"2011","journal-title":"Med. Oncol."},{"issue":"36","key":"10.1016\/j.canep.2023.102515_bib23","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1200\/JCO.2008.16.1927","article-title":"Phase I\/II study of ipilimumab for patients with metastatic melanoma","volume":"26","author":"Weber","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.canep.2023.102515_bib24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1056\/NEJMsb2019760","article-title":"The rapid rise in cutaneous melanoma diagnoses","volume":"384","author":"Welch","year":"2021","journal-title":"N. Engl. J. Med"},{"issue":"5","key":"10.1016\/j.canep.2023.102515_bib25","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jamainternmed.2013.2006","article-title":"The status of baby boomers' health in the United States: the healthiest generation?","volume":"173","author":"King","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"17","key":"10.1016\/j.canep.2023.102515_bib26","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1200\/JCO.2008.20.8983","article-title":"Future of cancer incidence in the United States: burdens upon an aging, changing nation","volume":"27","author":"Smith","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canep.2023.102515_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdp152","article-title":"Cutaneous malignant melanoma: ESMO clinical recommendations for diagnosis, treatment and follow-up","volume":"20","author":"Dummer","year":"2009","journal-title":"Ann. Oncol."},{"issue":"15","key":"10.1016\/j.canep.2023.102515_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13153866","article-title":"Age and cohort trends of malignant melanoma in the United States","volume":"13","author":"Lashway","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.canep.2023.102515_bib29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1200\/JCO.2010.28.7078","article-title":"Reduced melanoma after regular sunscreen use: randomized trial follow-up","volume":"29","author":"Green","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.canep.2023.102515_bib30","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/jnci\/djz153","article-title":"Melanoma incidence among non-hispanic whites in all 50 US States From 2001 Through 2015","volume":"112","author":"Thrift","year":"2019","journal-title":"JNCI: J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.canep.2023.102515_bib31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jamadermatol.2019.3353","article-title":"Age-specific incidence of melanoma in the United States","volume":"156","author":"Paulson","year":"2020","journal-title":"JAMA Dermatol."},{"issue":"6","key":"10.1016\/j.canep.2023.102515_bib32","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jid.2016.01.035","article-title":"The growing burden of invasive melanoma: projections of incidence rates and numbers of new cases in six susceptible populations through 2031","volume":"136","author":"Whiteman","year":"2016","journal-title":"J. Invest Dermatol."},{"issue":"22","key":"10.1016\/j.canep.2023.102515_bib33","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1001\/jama.292.22.2771","article-title":"Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria","volume":"292","author":"Abbasi","year":"2004","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.canep.2023.102515_bib34","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/jamadermatol.2013.4821","article-title":"Practice gaps: Delayed treatment and inadequate surgical margins for invasive melanoma in elderly patients","volume":"149","author":"Albertini","year":"2013","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.canep.2023.102515_bib35","doi-asserted-by":"crossref","first-page":"v194","DOI":"10.1093\/annonc\/mdq188","article-title":"Melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"21","author":"Dummer","year":"2010","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canep.2023.102515_bib36","article-title":"Ipilimumab pharmacotherapy in patients with metastatic melanoma","volume":"6","author":"Jeter","year":"2012","journal-title":"Clin. Med. Insight.: Oncol."},{"issue":"11","key":"10.1016\/j.canep.2023.102515_bib37","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/j.jid.2016.05.121","article-title":"Miscoding of Melanoma thickness in SEER: research and clinical implications","volume":"136","author":"Gimotty","year":"2016","journal-title":"J. Invest Dermatol."}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782123001959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782123001959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T15:27:53Z","timestamp":1736436473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782123001959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":37,"alternative-id":["S1877782123001959"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2023.102515","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The reduced mortality of malignant melanoma at the population level is mainly attributable to treatment advances for the past decade","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2023.102515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102515"}}